Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome

Clinical Chemistry

Volumn 51, Issue 8, 2005, Pages 1397-1404

  Ishii, Junnichi ^a   Ozaki, Yukio ^b   Lu, Jingchao ^b   Kitagawa, Fumihiko ^c   Kuno, Takahiro ^c   Nakano, Tadashi ^b   Nakamura, Yuu ^b   Naruse, Hiroyuki ^b   Mori, Yoshihisa ^b   Matsui, Shigeru ^b   Oshima, Hisaji ^c   Nomura, Masanori ^b   Ezaki, Kouji ^b   Hishida, Hitoshi ^b  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c FUJITA HEALTH UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; TROPONIN T;

ACUTE DISEASE; ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; CREATINE KINASE BLOOD LEVEL; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS;

ACUTE DISEASE; BIOLOGICAL MARKERS; CARRIER PROTEINS; CHEST PAIN; DEATH; FATTY ACID-BINDING PROTEINS; FOLLOW-UP STUDIES; HEART DISEASES; HOSPITALIZATION; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK; TIME FACTORS; TROPONIN T;

EID: 23044503371     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.047662     Document Type: Article

References (22)

1. Lin L, Sylvén C, Sotonyi P, Somogyi E, Kaijser L, Jansson E. Myoglobin content and citrate synthase activity in different parts of normal human heart. J Appl Physiol 1990;69:899-901.
2. Yoshimoto K, Tanaka T, Sohmiya K, Tsuji R, Okamoto F, Kawamura K, et al. Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction. Heart Vessels 1995;10:304-9.
3. Van Nieuwenhoven FA, Kleine AH, Wodzig KWH, Hermens WT, Kragten HA, Maesseen JG, et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995;92: 2848-54.
4. Ishii J, Wang J, Naruse H, Taga S, Kinoshita M, Kurokawa H, et al. Serum concentration of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997;43:1372-8.
5. Okamoto F, Sohmiya K, Ohkaru Y, Kawamura K, Asayama K, Kimura H, et al. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med 2000;38:231-8.
6. Seino Y, Ogata K, Takano T, Ishii J, Hishida H, Morita H, et al. Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Am J Med 2003;115:185-90.
7. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit; a two year experience with 250 patients. Am J Cardiol 1967;20:457-64.
8. Ohkaru Y, Asayama K, Ishii H, Nishimura S, Sunahara N, Tanaka T, et al. Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding protein. J Immunol Methods 1995;178:99-111.
9. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
10. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
11. Nakata T, Hashimoto A, Hase M, Tsuchihashi K, Shimamoto K. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology 2003;99:96-104.
12. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-53.
13. Bertrand ME, Simoons MI, Foz KAA, Wallentin LC, Hamm CW, McFadden E, et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendation of the Task Force of the European Society of Cardiology. Eur Heart J 2000;21:1406-32.
14. Blomkalns AL, Gibler WB. Early detection of myocardial necrosis in the emergency setting and utility of serum biomarkers in chest pain unit protocols. In: Wu AHB, ed. Cardiac markers, 2nd ed. Totowa, NJ: Humana Press, 2003:3-13.
15. Ohman EM, Armstrong PW, White HD, Granger CB, Wilcox RG, Weaver WD, et al. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. Am J Cardiol 1999;84:1281-6.
16. Matetzky S, Sharir T, Domingo M, Noc M, Chyu KY, Kaul S, et al. Elevated troponin I level on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction. Circulation 2000;102:1611-6.
17. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87.
18. Marrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, et al. Ability of minor elevations of troponin I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction. JAMA 2001;286: 2405-12.
19. Sohmiya K, Tanaka T, Tsuji R, Yoshimoto K, Nakayama Y, Hirota Y, et al. Plasma and urinary heart-type cytoplasmic fatty-acid binding protein in coronary occlusion and reperfusion induced myocardial injury model. J Mol Cell Cardiol 1993;65:1522-8.
20. Setsuta K, Seino Y, Ogawa T, Arao M, Miyatake Y, Takano T. Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. Am J Med 2002;113:717-22.
21. Pelsers MMAL, Hanhoff T, Van der Voort, Arts B, Peters M, Ponds R, et al. Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. Clin Chem 2004;50: 1568-75.
22. Steinacker P, Mollenhauer B, Bibl M, Cepek L, Esselmann H, Brechlin P, et al. Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases. Neurosci Lett 2004;370:36-9.